09.03.2020 RHÖN-KLINIKUM Aktiengesellschaft  DE0007042301

Medgate Deutschland GmbH: Supervisory Board Appoints Dr. Christian Braun as Second Managing Director


 


DGAP-Media / 09.03.2020 / 10:25

Bad Neustadt/Saale, Germany / Basel, Switzerland | 9th March 2020

 

Press Release
 

Supervisory Board of Medgate Deutschland GmbH Appoints Dr. Christian Braun as Second Managing Director


On 9th March 2020 the Supervisory Board of telemedicine provider Medgate Deutschland GmbH appointed Dr. Christian Braun as Chief Medical Officer alongside Verena Weissenseel who is Chair of Management. Dr. Braun is a specialist physician for internal medicine and FMH general internal medicine (Foederatio Medicorum Helveticorum - Swiss Medical Association) and also holds an additional title for clinical emergency and acute medicine.

"After establishing Medgate Deutschland we now have the future management team with Ms. Weissenseel and Dr. Braun who is a designated expert in the field of telemedicine and I am very pleased that he could be won as the CMO for Medgate Deutschland," stated Stephan Holzinger, Chairman of the Supervisory Board of Medgate Deutschland GmbH and CEO of RHÖN-KLINIKUM AG.

Dr. Christian Braun who has been working for Medgate in Switzerland as a Senior Physician and Medical Supervisor in Operative Management since 2018 stated: "I am looking forward to the new challenge and to being able to assist Medgate Deutschand with my expertise of many years in telemedicine as well as my extensive knowledge in using modern communication and information technologies. I am totally convinced that telemedicine will become a significant and firm component in German medical care."

Improving Healthcare in Germany

Medgate Deutschland's aim is to make an important contribution to improving healthcare in Germany by providing telemedicine and Digital Health services which are directed towards an increasingly digital-savvy society and their demands for efficient and fast healthcare of a high quality irrespective of time and place. The use of communication and information technologies is particularly interesting for people who are not registered with a GP, who live in a rural area or are constrained due to poor health and who do not have much time.

Medgate Deutschland offers telemedical advice and treatment irrespective of time or place on 365 days a year. If a person is ill, they just use their smartphone to receive medical advice and treatment either on the phone or by viewing a video. Patients have two methods to reach Medgate: they can use the Medgate app or they can contact Medgate by phone.

What has been reality in Switzerland for many years already will now also soon be possible in Germany. Medgate has already cared for more than 8.8 million patients with its telemedical services since it was established in 1999. It is one of the leading providers of telemedicine in Europe.

Contact

Elke Pfeifer, Head of Corporate Communications and Marketing
RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt / Saale, Germany
Telephone: +49 9771 65-12110, E-Mail:[email protected]

Cedric Berset, Director of Marketing, Communications & Sales
Medgate, Gellertstrasse 19, 4020 Basel, Switzerland
Telephone: +41 61 377 88 44, E-Mail: [email protected]

About Medgate Deutschland

Medgate Deutschland GmbH brings the physician to where he or she is needed by patients. We offer telemedical advice and treatment around the clock and 365 days a year. The focus of our activities is on the patient's well-being. In future Medgate Deutschland will offer patients advice and treatment via telephone and video conference within the statutory provisions applicable in Germany. Medgate Deutschland GmbH is a joint company owned by RHÖN-KLINIKUM AG and telemedicine provider Medgate which is registered in Basel, Switzerland. RHÖN-KLINIKUM holds 51 percent and Medgate has 49 percent of the shares in the company which is registered in Berlin, Germany. Patients benefit from the highly qualified specialist medical staff, high medical and technical standards as well as the innovative force of two strong partners and their experience of many decades united in Medgate Deutschland which they established in December 2019.



End of Media Release


Issuer: RHÖN-KLINIKUM Aktiengesellschaft
Key word(s): Enterprise

09.03.2020 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


992403  09.03.2020 

fncls.ssp?fn=show_t_gif&application_id=992403&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.211,08 1.232,91 1.303,90 1.360,16 1.402,01 1.446,09 1.463,98
EBITDA1,2 97,82 125,54 125,33 80,23 101,16 105,65 105,88
EBITDA-Marge3 8,08 10,18 9,61 5,90 7,22 7,31
EBIT1,4 38,70 64,94 56,80 10,60 30,52 36,11 40,40
EBIT-Marge5 3,20 5,27 4,36 0,78 2,18 2,50 2,76
Jahresüberschuss1 36,74 51,19 44,48 2,46 30,23 26,94 40,17
Netto-Marge6 3,03 4,15 3,41 0,18 2,16 1,86 2,74
Cashflow1,7 80,30 49,50 47,30 113,30 97,50 41,30 109,00
Ergebnis je Aktie8 0,53 0,73 0,65 0,02 0,42 0,38 0,58
Dividende8 0,22 0,29 0,00 0,00 0,00 0,15 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
Rhön-Klinikum
WKN Kurs in € Einschätzung Börsenwert in Mio. €
704230 10,900 Halten 729,89
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
18,17 28,00 0,64 18,63
KBV KCV KUV EV/EBITDA
0,58 6,70 0,50 6,30
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,15 0,00 0,00 05.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
0,87% -2,85% 9,00% -16,15%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu RHÖN-KLINIKUM Aktiengesellschaft  ISIN: DE0007042301 können Sie bei EQS abrufen


Pflegeeinrichtungen , 704230 , RHK , XETR:RHK